Genmab A/S
GNMSF
$249.00
-$0.45-0.18%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -72.82% | -94.64% | 65.52% | 65.52% | 1.56% |
| Total Depreciation and Amortization | 18.75% | 41.10% | -14.29% | 14.29% | 23.08% |
| Total Amortization of Deferred Charges | -- | -25.00% | -- | -- | -- |
| Total Other Non-Cash Items | 1,400.00% | 97.70% | -281.37% | -281.37% | 102.13% |
| Change in Net Operating Assets | -250.67% | 20,558.12% | -5.00% | -5.00% | 22.95% |
| Cash from Operations | -98.95% | -28.96% | -71.69% | -71.69% | 31.05% |
| Capital Expenditure | 58.33% | 7.73% | -150.00% | -150.00% | -200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -8,594.26% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.10% | 4,403.88% | -93.04% | -93.04% | 84.95% |
| Cash from Investing | 79.07% | -9,139.39% | 102.05% | 102.05% | 79.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,350.00% | -198.20% | -33.33% | -33.33% | 33.33% |
| Issuance of Common Stock | 100.00% | 167.28% | 200.00% | 200.00% | -88.89% |
| Repurchase of Common Stock | -816.67% | 87.23% | 7.06% | 7.06% | 86.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,261.54% | 24,375.65% | 7.73% | 7.73% | 84.71% |
| Foreign Exchange rate Adjustments | -237.50% | -122.72% | 64.29% | 64.29% | 900.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.17% | -112.80% | 78.54% | 78.54% | 410.39% |